Muscle Insider
New member
Hey there, sleepyheads! Rise and shine, because it’s time for The Morning Dose, your one-stop shop for all things that make your brain go “huh?”
This week we thought we’d do a peek into the world of…. SHUT DOWNs.
Ever logged onto your favorite peptide supplier and found a 404 page, or a missing website?
Well, it happens at least once a year and 2024 and this year has just been spoken for.
Welcome to the Morning Dose Paradigm Peptides shutdown edition!
First time reading? I’m Matt and this is The Morning Dose. Every week, our team scours 100s of sources to bring you need-to-know news and insights you won’t find elsewhere. All in 5 minutes. Were you forwarded this email? Sign up here.
Alert: Peptide Vendor Shut Down
Paradigm Peptides was a player in the market of research chemicals and peptides, catering to a niche yet significant audience interested in the scientific exploration of such compounds since 2017. Operating for nearly a decade, Paradigm Peptides had established itself as a go-to source for researchers and enthusiasts alike, looking for a wide range of peptides, SARMs (Selective Androgen Receptor Modulators), and other research chemicals. Their reputation was built on providing high-quality products and a wealth of information related to their use, dosage, and potential applications, distinguishing them from competitors in a highly scrutinized industry.
The Shutdown of Paradigm Peptides
The banner on the website now, see for yourself paradigmpeptides.com
This week, the unexpected shutdown of Paradigm Peptides caught the attention of many, marked initially by a seemingly innocuous “site undergoing maintenance” message on their website. This default WordPress maintenance notification raised eyebrows, prompting further investigation. Subsequent checks on the site revealed no progress, and attempts to contact the company through email went unanswered. It wasn’t long before the website’s message was updated to a more definitive “site is closed,” accompanied by a promise that all customers would receive refunds. This abrupt closure has left many in the community seeking answers and alternatives.
Investigating the Closure
The question of why Paradigm Peptides shut down, especially when similar companies appear to be operating without issue, is complex. A graph of their website traffic might have shown a thriving business, dealing in significant volumes of SARMs and other research chemicals. Yet, the practices that set Paradigm Peptides apart may also have been their downfall.
Unlike other research chemical suppliers that carefully market their products strictly for research purposes, Paradigm Peptides ventured into risky territory. Their extensive blog, filled with articles on usage, dosage, and detailed peptide application instructions, blurred the lines between research and practical use. This approach, while valuable for a segment of their audience, attracted scrutiny.
Regulatory Challenges
The letter from FDA
The link between their marketing practices and regulatory attention is not speculative. Paradigm Peptides previously received a warning letter from the FDA, specifically addressing their marketing strategies and the implied use of their products for Coronavirus
Such letters are a clear indication of the FDA’s stance on the sale and promotion of SARMs and peptides for human use, highlighting the legal and regulatory tightrope these companies must walk.
The Risks of Overexposure
A screenshot of the blog from an Archive.org screenshot
Paradigm Peptides’ strategy of providing in-depth content on peptide applications may have been a double-edged sword, offering both value to their customers and drawing unwanted regulatory attention. In the world of research chemicals, maintaining a balance between educating consumers and avoiding claims of promoting human consumption is crucial. Paradigm Peptides, it seems, may have leaned too far into the former, leading to their current predicament.
They were getting a significant amount of traffic to the blog due to organic search, see an estimation below.
Orangic traffic to ParadigmPeptides.com, notice the drop off at the end.
While details of the exact cause of their shutdown remain unclear, parallels can be drawn to other high-profile cases within the industry. Companies facing similar issues often endure raids, product confiscations, and legal challenges, although severe penalties are rare. The fate of Paradigm Peptides serves as a cautionary tale for the industry, underscoring the importance of navigating the fine line between providing valuable information and adhering to regulatory guidelines.
Moving Forward
As subscribers and advocates of research in this field, the closure of Paradigm Peptides is undoubtedly a setback. However, it also presents an opportunity to explore alternative sources for research chemicals. There are several reputable companies currently operating, and with the anticipated launch of new suppliers, the community remains vibrant and resilient. As we navigate these changes, our commitment to safe, informed, and responsible research remains steadfast.
While the sudden disappearance of Paradigm Peptides from the market leaves many questions unanswered, it also reinforces the need for vigilance and adherence to regulatory expectations within the research chemical community. As we look to the future, the lessons learned from this incident will undoubtedly shape the industry’s evolution, ensuring that exploration and innovation can continue within the bounds of safety and legality.
So, where can you buy peptides now? Check out below…
Best Peptide Vendor Alternative
Core Peptides has recently entered the market with a wide range of over 78 peptides and blends available for purchase on their website. As a new player in the industry, they may not have Certificates of Analysis (COAs) readily available for every product just yet. However, the company has expressed their commitment to ensuring that all products are thoroughly tested and verified before being made available for purchase.
Despite being a newcomer, Core Peptides has already made a positive impression on many of their customers. Their dedication to transparency and quality control is evident in their promise to make COAs available for all products very soon. In fact, they are continuously adding new tests to their current repertoire to ensure that their products meet the highest standards possible.
Forms: Injectable, topical and peptide blends
Lab Verified (COA): Mostly, but constantly being updated with new tests
Shipping Policy: Free for $200+ , Flat rate $9.95, Priority or $49.95 for Overnight
Payment Methods: Credit cards, Venmo, Zelle, CashApp
Guarantees: Free exchange for damaged product
Promo Codes: Waiting on promo codes!
Price (BPC157 5mg equivalent): $47
Rating: 4.67
Save 10% with CP10
Buy here..
Join Our Private Community of 1200+ biohackers
If you want to join a community of like-minded individuals, be sure to join our private Facebook group.
You’ll be able to ask your questions, get feedback from our head coach, Daniel Louwrens, and interact with other members of the Muscle and Brawn community.
Click Here to Join the Group
-The Morning Dose
PS – Have questions or suggestions? Hit reply and let us know what you think.
Disclaimer: This content is NOT medical advice. The information included in these emails is intended for entertainment and informational purposes only.
Powered by beehiiv
Click here to view the article.
This week we thought we’d do a peek into the world of…. SHUT DOWNs.
Ever logged onto your favorite peptide supplier and found a 404 page, or a missing website?
Well, it happens at least once a year and 2024 and this year has just been spoken for.
Welcome to the Morning Dose Paradigm Peptides shutdown edition!
Paradigm Peptides was a player in the market of research chemicals and peptides, catering to a niche yet significant audience interested in the scientific exploration of such compounds since 2017. Operating for nearly a decade, Paradigm Peptides had established itself as a go-to source for researchers and enthusiasts alike, looking for a wide range of peptides, SARMs (Selective Androgen Receptor Modulators), and other research chemicals. Their reputation was built on providing high-quality products and a wealth of information related to their use, dosage, and potential applications, distinguishing them from competitors in a highly scrutinized industry.
The Shutdown of Paradigm Peptides
The banner on the website now, see for yourself paradigmpeptides.com
This week, the unexpected shutdown of Paradigm Peptides caught the attention of many, marked initially by a seemingly innocuous “site undergoing maintenance” message on their website. This default WordPress maintenance notification raised eyebrows, prompting further investigation. Subsequent checks on the site revealed no progress, and attempts to contact the company through email went unanswered. It wasn’t long before the website’s message was updated to a more definitive “site is closed,” accompanied by a promise that all customers would receive refunds. This abrupt closure has left many in the community seeking answers and alternatives.
Investigating the Closure
The question of why Paradigm Peptides shut down, especially when similar companies appear to be operating without issue, is complex. A graph of their website traffic might have shown a thriving business, dealing in significant volumes of SARMs and other research chemicals. Yet, the practices that set Paradigm Peptides apart may also have been their downfall.
Unlike other research chemical suppliers that carefully market their products strictly for research purposes, Paradigm Peptides ventured into risky territory. Their extensive blog, filled with articles on usage, dosage, and detailed peptide application instructions, blurred the lines between research and practical use. This approach, while valuable for a segment of their audience, attracted scrutiny.
Regulatory Challenges
The letter from FDA
The link between their marketing practices and regulatory attention is not speculative. Paradigm Peptides previously received a warning letter from the FDA, specifically addressing their marketing strategies and the implied use of their products for Coronavirus
Such letters are a clear indication of the FDA’s stance on the sale and promotion of SARMs and peptides for human use, highlighting the legal and regulatory tightrope these companies must walk.
The Risks of Overexposure
A screenshot of the blog from an Archive.org screenshot
Paradigm Peptides’ strategy of providing in-depth content on peptide applications may have been a double-edged sword, offering both value to their customers and drawing unwanted regulatory attention. In the world of research chemicals, maintaining a balance between educating consumers and avoiding claims of promoting human consumption is crucial. Paradigm Peptides, it seems, may have leaned too far into the former, leading to their current predicament.
They were getting a significant amount of traffic to the blog due to organic search, see an estimation below.
Orangic traffic to ParadigmPeptides.com, notice the drop off at the end.
While details of the exact cause of their shutdown remain unclear, parallels can be drawn to other high-profile cases within the industry. Companies facing similar issues often endure raids, product confiscations, and legal challenges, although severe penalties are rare. The fate of Paradigm Peptides serves as a cautionary tale for the industry, underscoring the importance of navigating the fine line between providing valuable information and adhering to regulatory guidelines.
Moving Forward
As subscribers and advocates of research in this field, the closure of Paradigm Peptides is undoubtedly a setback. However, it also presents an opportunity to explore alternative sources for research chemicals. There are several reputable companies currently operating, and with the anticipated launch of new suppliers, the community remains vibrant and resilient. As we navigate these changes, our commitment to safe, informed, and responsible research remains steadfast.
While the sudden disappearance of Paradigm Peptides from the market leaves many questions unanswered, it also reinforces the need for vigilance and adherence to regulatory expectations within the research chemical community. As we look to the future, the lessons learned from this incident will undoubtedly shape the industry’s evolution, ensuring that exploration and innovation can continue within the bounds of safety and legality.
So, where can you buy peptides now? Check out below…
Core Peptides has recently entered the market with a wide range of over 78 peptides and blends available for purchase on their website. As a new player in the industry, they may not have Certificates of Analysis (COAs) readily available for every product just yet. However, the company has expressed their commitment to ensuring that all products are thoroughly tested and verified before being made available for purchase.
Despite being a newcomer, Core Peptides has already made a positive impression on many of their customers. Their dedication to transparency and quality control is evident in their promise to make COAs available for all products very soon. In fact, they are continuously adding new tests to their current repertoire to ensure that their products meet the highest standards possible.
Save 10% with CP10
Buy here..
Join Our Private Community of 1200+ biohackers
If you want to join a community of like-minded individuals, be sure to join our private Facebook group.
You’ll be able to ask your questions, get feedback from our head coach, Daniel Louwrens, and interact with other members of the Muscle and Brawn community.
Click Here to Join the Group
-The Morning Dose
PS – Have questions or suggestions? Hit reply and let us know what you think.
Disclaimer: This content is NOT medical advice. The information included in these emails is intended for entertainment and informational purposes only.
Powered by beehiiv
Click here to view the article.
